Liposome Drug Delivery Market Size By Regional Outlook (Europe, North America, Asia Pacific, Middle East & Africa And South America), Growth Potential, Price Trends, Competitive Market Share & Forecast 2023 - 2028 (Updated Version Available)
Date: Jan, 2021 | 168 Pages | Report ID: MRI_9210
Liposome Drug Delivery Market Size By Regional Outlook (Europe, North America, Asia Pacific, Middle East & Africa And South America), Growth Potential, Price Trends, Competitive Market Share & Forecast 2023 - 2028 (Updated Version Available)
ID : MRI9210 | Date : Jan, 2021 | Pages :
168 | Region : Global |
Publisher : MRI
The Liposome Drug Delivery market report provides a detailed analysis of global market size, value chain optimization, segmentation market growth, market share, competitive Landscape, regional and country-level market size, sales analysis, impact of domestic and global market players, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Liposome Drug Delivery market size is expected to gain market growth in the forecast period of 2023 to 2028, with a CAGR of xx%% in the forecast period of 2023 to 2028 and will expected to reach USD xx million by 2028, from USD xx million in 2020.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Liposomal Bupivacaine
Other Liposomals
By Application
Fungal Infection Therapy
Cancer & Tumor Therapy
Others
Competitive Landscape and Liposome Drug Delivery Market Share Analysis
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Teva Pharmaceutical
Ipsen (Onivyde)
Fudan-Zhangjiang
CSPC
Novartis
Kingond Pharm
Shanghai New Asia
Spectrum Pharmaceuticals
Liposome Drug Delivery competitive landscape provides details by vendors, including company overview, company total revenue (financial), market potential, global presence, Liposome Drug Delivery sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Liposome Drug Delivery sales, revenue and market share for each player covered in this report.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Liposome Drug Delivery market presented in the report. This section sheds light on the sales growth of different regional and country-level Liposome Drug Delivery markets. For the historical and forecast period 2018 to 2028, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Liposome Drug Delivery market.
Region Coverage (Regional Production, Demand & Forecast by Countries etc.): North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Liposome Drug Delivery market for the forecast period 2023 - 2028?
• What are the driving forces in the Liposome Drug Delivery market for the forecast period 2023 - 2028?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Liposome Drug Delivery industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?
Table of Content
1 Industrial Chain Overview
1.1 Liposome Drug Delivery Industry
1.1.1 Overview
Figure Liposome Drug Delivery Picture List
1.1.2 Characteristics of Liposome Drug Delivery
1.2 Upstream
1.2.1 Major Materials
1.2.2 Manufacturing Overview
1.3 Product List By Type
1.3.1 Liposomal Doxorubicin
1.3.2 Liposomal Amphoteracin B
1.3.3 Liposomal Paclitaxel
1.3.4 Liposomal Bupivacaine
1.3.5 Other Liposomals
1.4 End-Use List
1.4.1 Demand in Fungal Infection Therapy
1.4.2 Demand in Cancer & Tumor Therapy
1.4.3 Demand in Others
1.5 Global Market Overview
1.5.1 Global Market Size and Forecast, 2016-2026
Figure Global Market Size and Forecast with Growth Rate, 2016-2026
1.5.2 Global Market Size and Forecast by Geography with CAGR, 2016-2026
Table Global Market Size and Forecast by Geography with Growth Rate, 2016-2026
1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2016-2026
Table Global Market Size and Forecast by Type with Growth Rate, 2016-2026
1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2016-2026
Table Global Market Size and Forecast by End-Use with Growth Rate, 2016-2026
2 Global Production & Consumption by Geography
2.1 Global Production & Consumption
2.1.1 Global Production
Figure Global Production Volume Status and Growth Rate, 2016-2020, in Volume
Table Global Production Volume Status and Growth Rate by Geography, 2016-2020, in Volume
Figure Global Production Amount Status and Growth Rate, 2016-2020, in Million USD
Table Global Production Amount Status and Growth Rate by Geography, 2016-2020, in Million USD
2.1.2 Global Consumption
Figure Global Market Volume and Growth Rate, 2016-2020, in Volume
Table Global Market Volume and Growth Rate by Geography, 2016-2020, in Volume
Figure Global Market Amount and Growth Rate, 2016-2020, in Million USD
Table Global Market Amount and Growth Rate by Geography, 2016-2020, in Million USD
2.2 Geographic Production & Consumption
2.2.1 Production
2.2.1.1 Asia-Pacific
Figure Asia-Pacific Production Volume Status and Growth Rate, 2016-2020, in Volume
Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Figure Asia-Pacific Production Amount Status and Growth Rate, 2016-2020, in Million USD
Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
2.2.1.2 North America
Figure North America Production Volume Status and Growth Rate, 2016-2020, in Volume
Table North America Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Figure North America Production Amount Status and Growth Rate, 2016-2020, in Million USD
Table North America Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
2.2.1.3 South America
Figure South America Production Volume Status and Growth Rate, 2016-2020, in Volume
Table South America Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Figure South America Production Amount Status and Growth Rate, 2016-2020, in Million USD
Table South America Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
2.2.1.4 Europe
Figure Europe Production Volume Status and Growth Rate, 2016-2020, in Volume
Table Europe Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Figure Europe Production Amount Status and Growth Rate, 2016-2020, in Million USD
Table Europe Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
2.2.1.5 Middle East & Africa
Figure Middle East & Africa Production Volume Status and Growth Rate, 2016-2020, in Volume
Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Figure Middle East & Africa Production Amount Status and Growth Rate, 2016-2020, in Million USD
Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
2.2.2 Consumption
2.2.2.1 Asia-Pacific
Figure Asia-Pacific Market Volume and Growth Rate, 2016-2020, in Volume
Table Asia-Pacific Market Volume and Growth Rate by Region, 2016-2020, in Volume
Figure Asia-Pacific Market Amount and Growth Rate, 2016-2020, in Million USD
Table Asia-Pacific Market Amount and Growth Rate by Region, 2016-2020, in Million USD
2.2.2.2 North America
Figure North America Market Volume and Growth Rate, 2016-2020, in Volume
Table North America Market Volume and Growth Rate by Region, 2016-2020, in Volume
Figure North America Market Amount and Growth Rate, 2016-2020, in Million USD
Table North America Market Amount and Growth Rate by Region, 2016-2020, in Million USD
2.2.2.3 South America
Figure South America Market Volume and Growth Rate, 2016-2020, in Volume
Table South America Market Volume and Growth Rate by Region, 2016-2020, in Volume
Figure South America Market Amount and Growth Rate, 2016-2020, in Million USD
Table South America Market Amount and Growth Rate by Region, 2016-2020, in Million USD
2.2.2.4 Europe
Figure Europe Market Volume and Growth Rate, 2016-2020, in Volume
Table Europe Market Volume and Growth Rate by Region, 2016-2020, in Volume
Figure Europe Market Amount and Growth Rate, 2016-2020, in Million USD
Table Europe Market Amount and Growth Rate by Region, 2016-2020, in Million USD
2.2.2.5 Middle East & Africa
Figure Middle East & Africa Market Volume and Growth Rate, 2016-2020, in Volume
Table Middle East & Africa Market Volume and Growth Rate by Region, 2016-2020, in Volume
Figure Middle East & Africa Market Amount and Growth Rate, 2016-2020, in Million USD
Table Middle East & Africa Market Amount and Growth Rate by Region, 2016-2020, in Million USD
3 Major Manufacturers Introduction
3.1 Manufacturers Overview
Table Major Manufacturers Headquarters and Contact Information
Table Major Manufacturers Capacity List in 2018
3.2 Manufacturers List
3.2.1 Johnson & Johnson Overview
Table Johnson & Johnson Overview List
3.2.1.1 Product Specifications
3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Liposome Drug Delivery Business Operation of Johnson & Johnson (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.1.3 Recent Developments
3.2.1.4 Future Strategic Planning
3.2.2 Gilead Sciences Overview
Table Gilead Sciences Overview List
3.2.2.1 Product Specifications
3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Liposome Drug Delivery Business Operation of Gilead Sciences (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.2.3 Recent Developments
3.2.2.4 Future Strategic Planning
3.2.3 Pacira Overview
Table Pacira Overview List
3.2.3.1 Product Specifications
3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Liposome Drug Delivery Business Operation of Pacira (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.3.3 Recent Developments
3.2.3.4 Future Strategic Planning
3.2.4 Sun Pharmaceutical Overview
Table Sun Pharmaceutical Overview List
3.2.4.1 Product Specifications
3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Liposome Drug Delivery Business Operation of Sun Pharmaceutical (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.4.3 Recent Developments
3.2.4.4 Future Strategic Planning
3.2.5 Luye Pharma Overview
Table Luye Pharma Overview List
3.2.5.1 Product Specifications
3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Liposome Drug Delivery Business Operation of Luye Pharma (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.5.3 Recent Developments
3.2.5.4 Future Strategic Planning
3.2.6 Sigma-Tau Group Overview
Table Sigma-Tau Group Overview List
3.2.6.1 Product Specifications
3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Liposome Drug Delivery Business Operation of Sigma-Tau Group (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.6.3 Recent Developments
3.2.6.4 Future Strategic Planning
3.2.7 Teva Pharmaceutical Overview
Table Teva Pharmaceutical Overview List
3.2.7.1 Product Specifications
3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Liposome Drug Delivery Business Operation of Teva Pharmaceutical (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.7.3 Recent Developments
3.2.7.4 Future Strategic Planning
3.2.8 Ipsen (Onivyde) Overview
Table Ipsen (Onivyde) Overview List
3.2.8.1 Product Specifications
3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Liposome Drug Delivery Business Operation of Ipsen (Onivyde) (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.8.3 Recent Developments
3.2.8.4 Future Strategic Planning
3.2.9 Fudan-Zhangjiang Overview
Table Fudan-Zhangjiang Overview List
3.2.9.1 Product Specifications
3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Liposome Drug Delivery Business Operation of Fudan-Zhangjiang (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.9.3 Recent Developments
3.2.9.4 Future Strategic Planning
3.2.10 CSPC Overview
Table CSPC Overview List
3.2.10.1 Product Specifications
3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Liposome Drug Delivery Business Operation of CSPC (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.10.3 Recent Developments
3.2.10.4 Future Strategic Planning
3.2.11 Novartis Overview
Table Novartis Overview List
3.2.11.1 Product Specifications
3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Liposome Drug Delivery Business Operation of Novartis (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.11.3 Recent Developments
3.2.11.4 Future Strategic Planning
3.2.12 Kingond Pharm Overview
Table Kingond Pharm Overview List
3.2.12.1 Product Specifications
3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Liposome Drug Delivery Business Operation of Kingond Pharm (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.12.3 Recent Developments
3.2.12.4 Future Strategic Planning
3.2.13 Shanghai New Asia Overview
Table Shanghai New Asia Overview List
3.2.13.1 Product Specifications
3.2.13.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Liposome Drug Delivery Business Operation of Shanghai New Asia (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.13.3 Recent Developments
3.2.13.4 Future Strategic Planning
3.2.14 Spectrum Pharmaceuticals Overview
Table Spectrum Pharmaceuticals Overview List
3.2.14.1 Product Specifications
3.2.14.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Liposome Drug Delivery Business Operation of Spectrum Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.14.3 Recent Developments
3.2.14.4 Future Strategic Planning
4 Market Competition Pattern
4.1 Market Size and Sketch
Figure Global Market Size and Growth Rate, 2016-2020, in Volume
Figure Global Market Size and Growth Rate, 2016-2020, in Million USD
Figure Global Competition Sketch Overview
4.2 Company Market Share
4.2.1 Global Production by Major Manufacturers
Table Global Production Volume List by Manufacturers, 2016-2020, in Volume
Table Global Production Volume Share List by Manufacturers, 2016-2020, in Volume
Figure Global Production Volume Share by Manufacturers in 2020, in Volume
Table Global Production Amount List by Manufacturers, 2016-2020, in Million USD
Table Global Production Amount Share List by Manufacturers, 2016-2020, in Million USD
Figure Global Production Amount Share by Manufacturers in 2020, in Million USD
4.2.2 Market Concentration Analysis
4.3 Market News and Trend
4.3.1 Merger & Acquisition
4.3.2 New Product Launch
5 Product Type Segment
5.1 Global Overview by Product Type Segment
Table Global Market Status and Growth Rate by Product Type Segment, 2016-2020, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment 2016-2020, in Volume
5.2 Segment Subdivision by Product Type
5.2.1 Market in Liposomal Doxorubicin
5.2.1.1 Market Size
Figure Global Market Amount and Growth Rate in Liposomal Doxorubicin, 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Liposomal Doxorubicin, 2016-2020, in Volume
5.2.1.2 Situation & Development
5.2.2 Market in Liposomal Amphoteracin B
5.2.2.1 Market Size
Figure Global Market Amount and Growth Rate in Liposomal Amphoteracin B, 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Liposomal Amphoteracin B, 2016-2020, in Volume
5.2.2.2 Situation & Development
5.2.3 Market in Liposomal Paclitaxel
5.2.3.1 Market Size
Figure Global Market Amount and Growth Rate in Liposomal Paclitaxel, 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Liposomal Paclitaxel, 2016-2020, in Volume
5.2.3.2 Situation & Development
5.2.4 Market in Liposomal Bupivacaine
5.2.4.1 Market Size
Figure Global Market Amount and Growth Rate in Liposomal Bupivacaine, 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Liposomal Bupivacaine, 2016-2020, in Volume
5.2.4.2 Situation & Development
5.2.5 Market in Other Liposomals
5.2.5.1 Market Size
Figure Global Market Amount and Growth Rate in Other Liposomals, 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Other Liposomals, 2016-2020, in Volume
5.2.5.2 Situation & Development
6 End-Use Segment
6.1 Global Overview by End-Use Segment
Table Global Market Status and Growth Rate by End-Use Segment, 2016-2020, in Million USD
Table Global Market Status and Growth Rate by End-Use Segment 2016-2020, in Volume
6.2 Segment Subdivision
6.2.1 Market in Fungal Infection Therapy
6.2.1.1 Market Size
Figure Global Market Amount and Growth Rate in Fungal Infection Therapy, 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Fungal Infection Therapy, 2016-2020, in Volume
6.2.1.2 Situation & Development
6.2.2 Market in Cancer & Tumor Therapy
6.2.2.1 Market Size
Figure Global Market Amount and Growth Rate in Cancer & Tumor Therapy, 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Cancer & Tumor Therapy, 2016-2020, in Volume
6.2.2.2 Situation & Development
6.2.3 Market in Others
6.2.3.1 Market Size
Figure Global Market Amount and Growth Rate in Others, 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Others, 2016-2020, in Volume
6.2.3.2 Situation & Development
7 Market Forecast & Trend
7.1 Regional Forecast
Table Global Market Forecast by Region Segment 2021-2026, in Million USD
Table Global Market Forecast by Region Segment 2021-2026, in Volume
7.2 Consumption Forecast
7.2.1 Product Type Forecast
Table Global Market Amount by Product Type Segment 2021-2026, in Million USD
Table Global Market Volume by Product Type Segment 2021-2026, in Volume
7.2.2 End-Use Forecast
Table Global Market Amount by End-Use Segment 2021-2026, in Million USD
Table Global Market Volume by End-Use Segment 2021-2026, in Volume
7.3 Investment Trend
7.4 Consumption Trend
8 Price & Channel
8.1 Price and Cost
8.1.1 Price
8.1.2 Cost
Figure Cost Component Ratio
8.2 Channel Segment
9 Market Drivers & Investment Environment
9.1 Market Drivers
9.2 Investment Environment
9.3 Impact of Coronavirus on the Liposome Drug Delivery Industry
9.3.1 Impact on Industry Upstream
9.3.2 Impact on Industry Downstream
9.3.3 Impact on Industry Channels
9.3.4 Impact on Industry Competition
9.3.5 Impact on Industry Employment
10 Research Conclusion
Research Methodology
The Market Reports Insights offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.
Market Reports Insights are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
Well researched, expertise analysts, well organized, concrete and current topics delivered in time.
- President and CEO
Very helpful to understand overview of business status, by customers, categories, timeless, and regions. Able to build the future business strategy on the basis of research report. Validated and researched information of reports.
- Senior Manager, Product Development
We are very thankful to (company name) for detailed research report delivering in short period of time. Good market research Company really commendable.
- Senior Manager, Product Development
Excellent services, unique and very professional. The effort taken to make sure relevance to our requirements ensured the best possible outcome.
